{
  "meta": {
    "title": "Uip_Universal_Immunisation_Programme",
    "url": "https://brainandscalpel.vercel.app/uip-universal-immunisation-programme-8759028c.html",
    "scrapedAt": "2025-11-30T11:18:54.247Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Children less than two years old</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Sickle cell disease</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystic fibrosis</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Recurrent otitis and sinusitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 23-valent polysaccharide vaccine is available for Streptococcus pneumoniae. In which of the following patient populations is this vaccine most beneficial?</span></p>",
      "unique_key": "DT1230761",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230761,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The polysaccharide vaccine against Streptococcus pneumoniae, commonly known as the pneumococcal vaccine, is most beneficial in populations with increased susceptibility to severe pneumococcal infections.</li>\r\n<li>The 23-valent polysaccharide pneumococcal vaccine is recommended for:\r\n<ul>\r\n<li>Individuals aged &ge; 65 years.</li>\r\n<li>Adults 19-64 years with high-risk conditions like  CHF, DM, CLD, COPD, etc</li>\r\n<li>Immunocompromised individual</li>\r\n</ul>\r\n</li>\r\n<li>Individuals with sickle cell disease are at significantly increased risk of severe pneumococcal infections, including pneumonia and invasive pneumococcal disease.</li>\r\n<li>Their impaired immune function and increased susceptibility to infections make them particularly vulnerable to pneumococcal disease complications.</li>\r\n<li>Therefore, vaccination against Streptococcus pneumoniae, including the use of the polysaccharide vaccine, is highly beneficial in this population to reduce the risk of severe pneumococcal infections and associated complications.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Children less than two years (Option A):</strong> While children under two years of age are at higher risk of pneumococcal infections, including pneumonia, meningitis. Children under two years have immature immune systems and respond poorly to polysaccharide pneumococcal vaccines. Therefore, <strong>conjugate vaccines</strong> are preferred for effective protection against pneumococcal infections in this age group.</p>\r\n<p><strong>Cystic fibrosis (Option C): </strong>People with cystic fibrosis have a higher risk of pneumococcal infections and are best protected using a combination of conjugate and polysaccharide vaccines rather than the polysaccharide vaccine alone.</p>\r\n<p><strong>Recurrent otitis and sinusitis (Option D):</strong> Recurrent otitis media and sinusitis can involve Streptococcus pneumoniae, but the polysaccharide vaccine offers limited protection; additional preventive measures and treatments are often required.</p>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">The child should be given the second dose after four weeks</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">The child should be given a second dose as soon as she reaches nine months of age</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">The child should directly be given the second dose of measles at 16 months of age</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">The child should be given the second dose of measles vaccine at 12 months of age</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During a measles epidemic in a community, an 8 1/2-month-old child was vaccinated for measles. What is the correct schedule for the next dose of measles vaccination in this child?</span></p>",
      "unique_key": "DT1230775",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230775,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>During a measles epidemic, infants aged &lt;9 months may receive an early supplemental dose. Since this dose is not counted in the routine schedule, the routine first dose should still be given as soon as the child reaches 9 months of age.</p>\r\n<ul>\r\n<li>Children receive 2 doses of the measles vaccine as part of the routine immunisation.</li>\r\n<li>First dose should be given at<strong>9 months of age</strong> and the second dose <strong>between 15 and 18 months of age.</strong></li>\r\n<li>The minimum gap between two doses is <strong>4 weeks (28 days)</strong>, regardless of age.</li>\r\n<li>However, a <strong>supplementary dose of measles </strong>may be received by infants from 6 months of age, in situations such as:\r\n<ul>\r\n<li>During a measles outbreak, as part of intensified service delivery</li>\r\n<li>During campaigns in settings where the risk of measles among infants &lt; 9 months of age remains high</li>\r\n<li>For individual infants at high risk of contracting measles (e.g. contacts of known measles cases or in settings with increased risk of exposure during outbreaks such as day-care facilities)</li>\r\n<li>For infants travelling to countries experiencing measles outbreaks</li>\r\n<li>For infants known to be HIV-infected or exposed (i.e. born to an HIV-infected woman)</li>\r\n</ul>\r\n</li>\r\n<li>Children who receive a supplementary dose should also receive the routine 1st and 2nd doses at recommended ages according to the national schedule.</li>\r\n</ul>",
      "correct_choice_id": 11,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Influenza</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Diphtheria</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Polio</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Typhoid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which vaccine requires periodic strain updates because the causative organism undergoes frequent antigenic changes?</span></p>",
      "unique_key": "DT1230798",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230798,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The influenza vaccine requires <strong>annual strain updates</strong> to match circulating viruses and ensure optimal protection.</p>\r\n<ul>\r\n<li>The influenza virus is known for its ability to undergo frequent antigenic changes, particularly in the surface proteins hemagglutinin (HA) and neuraminidase (NA).</li>\r\n<li>These changes may be gradual - <strong>antigenic drift</strong>or drastic - <strong>antigenic shift </strong>and resulting in the emergence of new influenza virus strains.</li>\r\n<li>As a result, seasonal influenza vaccines need to be updated annually to match the circulating strains and provide optimal protection against infection.</li>\r\n<li>Two types of influenza viruses are included in the influenza vaccine: human influenza A virus and influenza B virus.</li>\r\n<li>Vaccine composition is reviewed annually and updated as needed based on the circulating viruses, the extent to which those viruses are spreading, and how good the response was to the previous year's vaccine.</li>\r\n<li>The World Health Organisation makes recommendations about the specific viruses to be included.d</li>\r\n</ul>\r\n<p><strong>Explanation of other options</strong></p>\r\n<p><strong>Diphtheria (Option B):</strong> Diphtheria, caused by Corynebacterium diphtheriae, is prevented using a stable toxoid vaccine (e.g., DTaP) that provides long-lasting immunity against its toxin. Frequent strain changes are unnecessary because the bacterium is antigenically stable.</p>\r\n<p><strong>Polio (Option C):</strong> Poliomyelitis is caused by three poliovirus serotypes, types 1, 2, and 3. Both the oral polio vaccine (OPV) and inactivated polio vaccine (IPV) protect against all three serotypes, and unlike influenza, they also do not require frequent strain updates, as the virus is antigenically stable.</p>\r\n<p><strong>Typhoid (Option D):</strong> Typhoid fever, caused by Salmonella enterica serotype Typhi, is prevented using Vi polysaccharide or Ty21a live attenuated vaccines. Strain changes are rarely needed, as these vaccines target stable antigens common to most S. Typhi strains.</p>",
      "correct_choice_id": 21,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">OPV and BCG only</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Pentavalent only</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">DPT, OPV and Measles</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\"> Pentavalent, BCG, OPV and MMR</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An 18-month-old child comes for vaccination for the first time. Which of the following vaccines can be given at this visit?</span></p>",
      "unique_key": "DT1231307",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231307,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>At 18 months of age, infants should receive vaccinations according to the recommended immunisation schedule.</li>\r\n<li>These include DPT (Diphtheria, Pertussis, Tetanus), OPV (Oral Polio Vaccine), and Measles vaccines. More specifically:\r\n<ul>\r\n<li>MR 1st dose</li>\r\n<li>JE 1st dose</li>\r\n<li>DPT booster 1</li>\r\n<li>OPV booster</li>\r\n</ul>\r\n</li>\r\n<li>These vaccines protect against diphtheria, pertussis, tetanus, polio, and measles, which are all important diseases to prevent in childhood.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250925def63a39-7d31-4e3a-a05b-684384faa265.png\">\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>OPV and BCG only (Option A):</strong> BCG vaccine is typically administered at birth to protect against tuberculosis, while OPV (Oral Polio Vaccine) is given multiple times during infancy. However, at 18 months, the child should receive additional vaccines beyond OPV and BCG.</p>\r\n<p><strong>Pentavalent only (Option B):</strong> Pentavalent vaccine typically includes protection against diphtheria, pertussis (whooping cough), tetanus, hepatitis B, and Haemophilus influenzae type b (Hib). While the Pentavalent vaccine is important, it does not cover all the recommended vaccines for an 18-month-old child.</p>\r\n<p><strong>Pentavalent, BCG, OPV and MMR (Option D): </strong>While this option includes a combination of several vaccines, the MMR vaccine is typically administered at 12-15 months of age, not at 18 months.</p>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">A & B can be used</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">A & C can be used</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">B & D can be used</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">C & D can be used</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which vaccine vial monitors indicate that the vaccine can still be used?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241105c495754e-fae3-4a50-afaf-7dc06efecd1f.jpeg\"></span></p>",
      "unique_key": "DT1231309",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231309,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>As per the vaccine vial monitors,  A and B can be used.</strong></p>\r\n<ul>\r\n<li>Vaccine vial monitors (VVMs) are<strong>chemical indicator labels</strong> affixed to vaccine vials to indicate whether the vaccine has been exposed to heat or has lost its potency.</li>\r\n<li>Vaccine vial monitors are the only<strong>temperature monitoring devices</strong> that routinely accompany vaccines throughout the entire supply chain.</li>\r\n<li>They help healthcare workers determine whether a vaccine is safe to use, especially in areas with unreliable access to refrigeration.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509255fc05c66-d770-4952-acc6-5589ebce56b2.png\">\r\n<p>The stages of vaccine vial monitors typically include the following:</p>\r\n<ul>\r\n<li><strong>Stage 1:</strong> The inner square is white - use the vaccine.</li>\r\n<li><strong>Stage 2:</strong>The inner square is lighter than the outer circle - use&nbsp;the vaccine.</li>\r\n<li><strong>Stage 3: </strong>Discard point, the colour of the inner square matches that of the outer circle - do not use the vaccine.</li>\r\n<li><strong>Stage 4:</strong>Beyond the discard point, the inner square is darker than the outer circle - do not use the vaccine.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250925202509255fc05c66-d770-4952-acc6-5589ebce56b21.png\">",
      "correct_choice_id": 41,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">6</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">31</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">32</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">33</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following serotypes is not included in the nonvalent HPV vaccine?</span></p>",
      "unique_key": "DT1231320",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231320,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>HPV type 32 is not included in the nonavalent HPV vaccine.</p>\r\n<ul>\r\n<li>The nonvalent HPV vaccine, also known as <strong>Gardasil 9,</strong>protects against nine types of human papillomavirus (HPV) that are associated with various cancers and genital warts.</li>\r\n<li>The HPV serotypes included are:\r\n<ul>\r\n<li>HPV types 6 and 11: These types cause about 90% of genital wart cases.</li>\r\n<li>HPV types 16, 18, 31, 33, 45, 52, and 58: These types are associated with several cancers, including cervical, vulvar, vaginal, anal, and oropharyngeal cancers.</li>\r\n</ul>\r\n</li>\r\n<li>Gardasil was the <strong>first FDA-approved HPV vaccine.</strong></li>\r\n<li>It is routinely given at <strong>11-12 year</strong>s but can be started as early as 9 years.</li>\r\n<li>Children aged 11-12 years require 2 doses 6-12 months apart, while those aged 15-26 years starting later need 3 doses over 6 months.</li>\r\n<li>Vaccination is not routinely recommended after 26 years.</li>\r\n</ul>",
      "correct_choice_id": 53,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Measles</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">TB</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Tetanus</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Meningococcus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following diseases are covered under Mission Indradhanush, except:</span></p>",
      "unique_key": "DT1231323",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231323,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Meningococcal vaccines are not included in the standard immunisation schedule under Indradhanush.</p>\r\n<ul>\r\n<li>Mission Indradhanush is a Government of India program launched in December 2014 to protect children from seven vaccine-preventable diseases.</li>\r\n<li>It targets all unvaccinated and partially vaccinated children under 2 years, as well as those aged 2-5 years, to complete their immunisation, and also covers pregnant women.</li>\r\n<li>Intensified Mission Indradhanush is the expanded phase of the program launched in October 2017.</li>\r\n<li>The diseases covered under the intensified Indradhanush program include:\r\n<ul>\r\n<li>Measles</li>\r\n<li>Tuberculosis (TB)</li>\r\n<li>Tetanus</li>\r\n<li>Polio</li>\r\n<li>Diphtheria</li>\r\n<li>Pertussis (Whooping cough)</li>\r\n<li>Hepatitis B</li>\r\n<li>Meningitis and pneumonia - Hemophilus influenzae B</li>\r\n</ul>\r\n</li>\r\n</ul>",
      "correct_choice_id": 64,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">2 weeks</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">4 weeks</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">6 weeks</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">2 months</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Minimum gap between two live vaccines</span></p>",
      "unique_key": "DT1231327",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231327,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The minimum gap between two live vaccines is typically recommended to be at <strong>least 4 weeks</strong>.</li>\r\n<li>An adequate gap between vaccines allows the immune system enough time to respond fully to the first vaccine before administering the second one.</li>\r\n<li>This interval helps ensure that each vaccine can<strong>induce a robust immune response</strong> without interference from the other vaccine and <strong>minimise the risk of adverse events</strong> before administering the second one.</li>\r\n<li>This interval helps ensure that each vaccine can induce a robust immune response without interference from the other vaccine.</li>\r\n</ul>",
      "correct_choice_id": 72,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Within 12 hours</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Within 24 hours</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Within 48 hours</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Within 72 hours</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Under the national immunisation schedule, within how many hours after birth should the first dose of the hepatitis B vaccine be given to a newborn?</span></p>",
      "unique_key": "DT1231606",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231606,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The first dose of the hepatitis B vaccine is typically given to newborns shortly after birth, ideally within the first 24 hours of life.</li>\n<li>Administering the vaccine soon after birth helps provide early protection against hepatitis B virus (HBV) infection, especially in infants born to HBV-infected mothers who may be at high risk of perinatal transmission.</li>\n<li>In India, Hepatitis B vaccination follows a four-dose schedule, a birth dose, followed by doses at 6, 10, and 14 weeks (often as pentavalent with DPT and Hib.</li>\n<li>At birth, only the monovalent Hepatitis B vaccine is used.</li>\n</ul>",
      "correct_choice_id": 82,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">The birth dose of hepatitis B should be given within 72 hours</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Pentavalent vaccine comprises Diphtheria, pertussis, tetanus, pneumococcal, and hepatitis B</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">BCG, OPV and hepatitis B vaccine are given at birth</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">OPV can be given to children till 7 years.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements regarding the National Immunisation Schedule is/are correct?</span></p>",
      "unique_key": "DT1231607",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231607,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The vaccines given at birth to a baby typically include:\n<ul>\n<li>BCG</li>\n<li>OPV zero dose</li>\n<li>Hepatitis B first dose</li>\n</ul>\n</li>\n<li>These vaccines provide early protection against tuberculosis, poliovirus, and hepatitis B virus, respectively, during the vulnerable newborn period.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250925d2fa3a64-b0e9-437a-a240-18f99eab04bd.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>The birth dose of hepatitis B should be given within 72 hours (Option A): </strong>The first dose of hepatitis B vaccine is given to newborns ideally within 24 hours of birth to provide early protection against HBV, especially in infants at high risk of mother-to-child transmission.</p>\n<p><strong>Pentavalent vaccine comprises Diphtheria, pertussis, tetanus, pneumococcal, and hepatitis B (Option B): </strong>Pentavalent vaccine typically includes protection against diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae b. It does not include the pneumococcal vaccine.</p>\n<p><strong>OPV can be given to children till 7 years (Option D): </strong>OPV is generally given to children up to 5 years of age. After that, routine immunisation with OPV is not standard.</p>",
      "correct_choice_id": 93,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">It is given as a 0.5 ml intramuscular injection at 6, 10, and 14 weeks of age</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">The vaccine is administered in the deltoid muscle of the arm in infants</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">The pentavalent vaccine is recommended only up to 6 months of age</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">If a child misses the first dose, the vaccine cannot be given later</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements about the pentavalent vaccine is correct?</span></p>",
      "unique_key": "DT1231609",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231609,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The pentavalent vaccine is a combination vaccine that offers protection against five diseases: diphtheria, pertussis, tetanus, hepatitis B, and Haemophilus influenzae type b.</li>\n<li>Pentavalent vaccine is a<strong>freeze-sensitive vaccine</strong> and should be stored and transported at 2-8&deg;C.</li>\n<li>The pentavalent vaccine is administered as a 0.5 ml intramuscular injection.</li>\n<li>It is given at 6, 10, and 14 weeks of age.</li>\n<li>The preferred injection site is the <strong>anterolateral aspect of the mid-thigh</strong>. <em>(Option B ruled out)</em></li>\n<li>It is recommended for children up to 1 year of age. <em>(Option C ruled out)</em></li>\n<li>If a child is unimmunized and presents after 1 year of age, the DPT vaccine is given instead.</li>\n<li>If the first dose of the pentavalent vaccine has been given but subsequent doses were missed, the pentavalent vaccine can still be continued beyond 1 year of age to complete the schedule. <em>(Option D ruled out)</em></li>\n</ul>",
      "correct_choice_id": 101,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral polio vaccine</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenovirus vaccine</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Rotavirus vaccine</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Influenza vaccine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following vaccines has been most commonly associated with an increased risk of intussusception in infants?</span></p>",
      "unique_key": "DT1231611",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231611,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Intussusception is a rare but serious adverse event associated with rotavirus vaccination.</p>\n<p><strong>Rotavirus vaccine:</strong></p>\n<ul>\n<li>There are two oral rotavirus vaccines available: <strong>Rotarix</strong>and <strong>RotaTeq</strong>.</li>\n<li>Rotarix is given in two doses, typically at 6 and 10 weeks of age</li>\n<li>RotaTeq is given in three doses at 2, 4, and 6 months.</li>\n<li>Rotavirus vaccines are highly effective in preventing severe diarrhoea caused by rotavirus infection, which is a leading cause of severe gastroenteritis and dehydration in infants and young children worldwide.</li>\n<li>Vaccination should not be initiated for infants aged &gt; 12 weeks.</li>\n<li>There is a potentially<strong>higher risk of intussusception</strong> when the first dose of these vaccines is given to<strong> infants aged &gt;12 weeks</strong>.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Oral polio vaccine (Option A):</strong> Oral polio vaccine is a live attenuated vaccine and is remarkably free from complications. However, it rarely causes vaccine-associated paralytic polio due to reversion of the vaccine virus to a more virulent form; it is not associated with intussusception.</p>\n<p><strong>Adenovirus vaccine (Option B):</strong> Adenovirus vaccine is not associated with intussusception. Adenovirus vaccines are typically used among military personnel and are not part of routine childhood immunisation schedules. Adenovirus vaccines typically cause mild side effects such as fever, sore throat, headache, and fatigue.</p>\n<p><strong>Influenza vaccine (Option D):</strong> Influenza vaccine, whether in inactivated or live attenuated forms, is not associated with intussusception. They are mostly associated with side effects like fever, muscle or joint aches, and headaches. In rare cases, influenza vaccines can trigger allergic reactions such as hives, deep tissue swelling, asthma, or severe multisystem hypersensitivity.</p>",
      "correct_choice_id": 113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Start ART when CD4 < 200</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Start ART first, then ATT after 2 weeks</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Start ATT first, then ART after 2 weeks</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Start ART and ATT simultaneously</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient is diagnosed with both tuberculosis and HIV as a co-infection. What is the recommended treatment protocol?</span></p>",
      "unique_key": "DT1231612",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231612,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>If a Person is positive for both HIV &amp;TB, treatment for TB should be started first, and  ATT is given for a minimum of 2 weeks, followed by ART.</p>\n<p><strong>Treatment of HIV-TB Coinfection:</strong></p>\n<ul>\n<li>Cellular immunity is responsible for manifestations of TB</li>\n<li>In HIV, as the CD4 count is low, the symptoms of TB are minimal</li>\n<li>If a patient with HIV and TB is started on ART, cellular immunity increases, and there is a flare-up of symptoms of TB, this is called IRIS - <strong>immune reconstitution inflammatory syndrome</strong>.</li>\n<li>Therefore, ATT is started first, followed by ART after 2 weeks to 2 months.</li>\n<li>However, if the CD4 count is below 50, ART and ATT are started simultaneously. <em>(Option A, C ruled out)</em></li>\n<li>Additionally, patients with HIV and TB co-infection are given cotrimoxazole prophylaxis treatment.</li>\n<li>Also, rifampicin is replaced by rifabutin because rifampicin decreases the bioavailability of other drugs.</li>\n</ul>",
      "correct_choice_id": 123,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Td/TT</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">MMR</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Pentavalent</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">JE</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which vaccine is typically administered to a 10-year-old child as part of school immunisation programs?</span></p>",
      "unique_key": "DT1231613",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231613,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Td vaccine is given to children around 10 years of age as a booster dose as part of school-based immunisation programs.</p>\n<ul>\n<li>Td vaccine contains<strong>tetanus</strong> and a lower dose of <strong>diphtheria toxoid</strong>.</li>\n<li>It is given as a booster dose to children at 10 years and again at 16 years of age.</li>\n<li>It protects against tetanus and diphtheria, two bacterial infections that can cause severe illness and complications if left untreated.</li>\n<li>The booster dose helps ensure long-lasting immunity against these diseases, as immunity from childhood vaccination may wane over time.</li>\n<li>For younger children up to 5 years old, the DPT vaccine is administered. The DPT vaccine is given at 6 weeks, 10 weeks, 14 weeks, 1.5 years, and 5 years of age.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>MMR (Option B): </strong>The MMR vaccine is typically administered in two doses, with the first dose given around 12-15 months of age and the second dose given at 4-6 years of age. While the MMR vaccine is essential for preventing measles, mumps, and rubella, it is not typically administered as part of school-based immunisation programs for 10-year-old children.</p>\n<p><strong>Pentavalent (Option C): </strong>The pentavalent vaccine is given as a 0.5 ml intramuscular injection at 6, 10, and 14 weeks of age in the anterolateral thigh. It is usually administered to infants as part of routine childhood immunisation schedules.</p>\n<p><strong>JE (Option D): </strong>Under the routine immunisation programme, the JE vaccine is given in two doses: the first with the measles vaccine at 9 months and the second with the DPT booster between 16-24 months.</p>",
      "correct_choice_id": 131,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Killed and oral</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Killed and subcutaneous</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Live and intramuscular</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Killed and intramuscular</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During an encephalitis outbreak among school children caused by inadequate childhood vaccination, which type and route of vaccine, according to the Universal Immunisation Programme, could have prevented this?</span></p>",
      "unique_key": "DT1231614",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231614,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation :</strong></p>\n<ul>\n<li>Encephalitis outbreaks in children are often caused by viruses like Japanese Encephalitis, which can be prevented by the JE vaccine.</li>\n<li>Under the Universal Immunisation Programme, it is given only in endemic states and districts.</li>\n<li>Japanese Encephalitis vaccination in India uses a live attenuated SA 14-14-2 strain vaccine.</li>\n<li>The dose is 0.5 ml, administered subcutaneously in the left upper arm.</li>\n<li>JE vaccination schedule:\n<ul>\n<li>1st dose: At 9-12 months of age</li>\n<li>2nd dose: At 1&frac12; years</li>\n</ul>\n</li>\n<li>In high-risk endemic districts, adults aged 15 years and above in Assam, Uttar Pradesh, and West Bengal are targeted for Japanese Encephalitis (JE) vaccination. The vaccine used is JENVAC, an inactivated Vero cell-derived vaccine produced in India, administered intramuscularly.</li>\n</ul>",
      "correct_choice_id": 143,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer rabies vaccine on days 0, 3, 7, 14, and 28</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Clean the wound thoroughly with soap and water for at least 10 minutes</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer human rabies immunoglobulin</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Suture the wound immediately</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old man presents to the emergency room with a wound on his lower leg from a dog bite. On examination, the wound is actively bleeding. Which of the following is not recommended in the management of this patient?</span></p>",
      "unique_key": "DT1231615",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231615,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>This clinical scenario represents a Category III dog bite, requiring thorough wound cleaning, administration of the rabies vaccine, and rabies immunoglobulin.</li>\n<li>However, any bite wounds should not be immediately sutured to prevent additional trauma, which may help spread the virus into deeper tissues.</li>\n<li>If suturing is necessary, it should be done 24-48 hours later, applying the minimum possible stitches, under the cover of rabies immunoglobulin locally.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509254d64c374-823c-4b8b-bc97-2d459fa2b52f.png\">\n<p><strong>Local treatment of the wound:</strong></p>\n<ul>\n<li>Prompt and adequate local treatment of all bite wounds and scratches is the first prerequisite and is of utmost importance.</li>\n<li>It includes thorough cleansing of the wound with soap and running water for 15-20 minutes and anti-biotics and anti-tetanus measures.</li>\n</ul>\n<p><strong>Immunisation:</strong></p>\n<ul>\n<li>Intradermal regimen (Thai-red cross regimen): 2 doses, 0.1 ml each, on days 0,3,7 and 28.</li>\n<li>Intramuscular regimen (Essen regimen): Single dose, 1 ml or 0.5 ml, on days 0,3,7,14,28</li>\n</ul>\n<p><strong>Human Rabies immunoglobulin (HRIG):</strong></p>\n<ul>\n<li>HRIG provides immediate passive immunity by neutralising the rabies virus at the wound site.</li>\n<li>It is given as a single dose calculated based on body weight at 20 IU/kg for human rabies immunoglobulin (HRIG) or 40 IU/kg for equine rabies immunoglobulin (ERIG).<br />It is infiltrated as much as possible around and into the wound.</li>\n<li>Any remaining volume, if not infiltrated locally, is given intramuscularly at a site distant from the vaccine injection.</li>\n</ul>",
      "correct_choice_id": 154,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">1,00,000 IU</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">50,000 IU</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">2,00,000 IU</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">1,50,000 IU</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An 8-month-old child has just received the MMR vaccine. What is the appropriate dose of vitamin A to be given today?</span></p>",
      "unique_key": "DT1231620",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231620,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The recommended dose of vitamin A supplementation for an 8-month-old child after MMR vaccination is typically 100,000 IU.</p>\n<ul>\n<li>Vitamin A supplementation is recommended in areas with high vitamin A deficiency or increased risk of infections like measles.</li>\n<li>Measles infection can deplete vitamin A levels, increasing the risk of complications.</li>\n<li>Therefore, after measles vaccination, children are given vitamin A to replenish their stores and boost protection against infections.</li>\n<li>This helps support the child's immune system and reduces the risk of complications from measles and other infectious diseases.</li>\n</ul>\n<p><strong>Vitamin A Supplementation Schedule:</strong></p>\n<ul>\n<li>9 to 12 months: 100,000 IU orally</li>\n<li>Every 6 months thereafter until 5 years of age: 200,000 IU orally</li>\n</ul>",
      "correct_choice_id": 161,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Wound care, intradermal rabies vaccine, and rabies immunoglobulin</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Wound care and intradermal rabies vaccine on days 0 and 3</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Wound care and intradermal rabies vaccine on days 0, 3, and 7</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Wound care only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with a Category III bite from a stray dog. She received post-exposure rabies vaccination for a monkey bite 2 months ago. What is the appropriate management now?</span></p>",
      "unique_key": "DT1231623",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231623,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Since the patient was vaccinated 2 months ago, she is considered previously immunised. According to guidelines, if an individual has received PEP within the last three months, only thorough wound washing is necessary. There is no need for additional vaccination or immune globulin administration.</p>\n<p><strong>Guidelines for Re-exposure prophylaxis for previously vaccinated individuals:</strong></p>\n<p>For rabies-exposed patients with documented previous complete pre-exposure vaccination or post-exposure prophylaxis, the following guidelines are followed:</p>\n<ul>\n<li>Proper wound management should be done</li>\n<li>No need for administration of HRIG</li>\n<li>Rabies vaccine administration:\n<ul>\n<li>Single-site intradermal vaccine, 0.1 ml on days 0 and 3<br />or</li>\n<li>Single-site intramuscular administration of an entire vaccine vial on days 0 and 3.</li>\n</ul>\n</li>\n<li>This 1-site, 2-day intradermal or intramuscular regimen also applies to those with confirmed rabies-virus neutralising antibody titres &ge;0.5 IU/ml.</li>\n<li>However, if an individual has received PEP <strong>within the last three months</strong>, only <strong>thorough wound washing</strong>is necessary.</li>\n</ul>",
      "correct_choice_id": 174,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Use both Pentavalent & MR open vial</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Discard both Pentavalent & MR open Vial</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Use Pentavalent vial & discard MR vial</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Use MR vial & discard Pentavalent vial</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">At an urban Primary Health Centre, you have one open vial of Pentavalent vaccine and two open vials of MR vaccine. Assuming all cold chain requirements have been maintained, what is the appropriate action?</span></p>",
      "unique_key": "DT1231640",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231640,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>According to the open vial policy, the MR vaccine must be discarded after opening, whereas the Pentavalent vaccine can be used for multiple sessions if cold chain conditions are maintained.</p>\n<p><strong>Open vial policy:</strong></p>\n<p>Implementation of the open vial policy allows the reuse of partially used multidose vials of applicable vaccines in subsequent sessions to reduce vaccine wastage.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250925380bb326-d014-4d0f-9c05-44cda91aef03.png\">\n<ul>\n<li>Vaccine vials that follow the open vial policy, if opened in a session-site, can be used in more than one immunisation session up to four weeks, provided:\n<ul>\n<li>Vaccine Vial Monitor is intact</li>\n<li>The vaccine has been properly stored in the Ice-Lined Refrigerator</li>\n<li>Expiry date has not passed.</li>\n</ul>\n</li>\n<li>All open vials of BCG, Measles and JE should be destroyed after 48 hours or before the next session, whichever is earlier.</li>\n</ul>",
      "correct_choice_id": 183,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Treatment completed</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Cured</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Improper follow-up</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Failure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with a 3-week history of cough was started on ATT under the National Tuberculosis Elimination Program. After completing the intensive and continuation phases of treatment, the sputum smear tested negative for AFB on two samples. What is the patients treatment outcome status?</span></p>",
      "unique_key": "DT1231642",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231642,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Since the patient completed treatment and has two consecutive negative sputum smears for AFB, this confirms bacteriological cure and the status is classified as Cured.</p>\n<p><strong>TB treatment outcomes for both Drug-sensitive TB and Drug-resistant TB:</strong></p>\n<ul>\n<li><strong>Treatment failed: </strong>A patient whose treatment regimen needed to be terminated or permanently changed to a new regimen or treatment strategy. <em>(Option D ruled out)</em></li>\n</ul>\n<ul>\n<li><strong>Cured: </strong>A patient with pulmonary TB with bacteriologically confirmed TB at the beginning of treatment, who completed treatment as recommended by the national policy, with evidence of bacteriological response and no evidence of failure.</li>\n</ul>\n<ul>\n<li><strong>Treatment completed: </strong>A patient who completed treatment as recommended by the national policy, but whose outcome does not meet the definition for cure or treatment failure. <em>(Option A ruled out)</em></li>\n</ul>\n<ul>\n<li><strong>Died: </strong>A patient who died before starting treatment or during treatment.</li>\n</ul>\n<ul>\n<li><strong>Lost to follow-up: </strong>A patient who did not start treatment or whose treatment was interrupted for 2 consecutive months or more. <em>(Option C ruled out)</em></li>\n</ul>\n<ul>\n<li><strong>Not evaluated: </strong>A patient for whom no treatment outcome was assigned.</li>\n</ul>\n<ul>\n<li><strong>Treatment success: </strong>The sum of all patients cured and treatment completed.</li>\n</ul>",
      "correct_choice_id": 192,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Test all the dogs for Rabies</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Eliminate stray dogs and vaccinate the remaining dog population</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Vaccinate the entire human population against rabies</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Provide health education to the public</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most logical and cost-effective strategy for controlling rabies in an urban population?</span></p>",
      "unique_key": "DT1231643",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231643,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Since the dog is the major source of infection, the most logical and cost-effective approach is the <strong>elimination of stray and ownerless dogs</strong>combined with a programme of swift <strong>mass immunisation</strong>.</li>\n<li>Prophylactic vaccination of dogs against rabies is one of the most important weapons in rabies control.</li>\n<li>Other methods include:\n<ul>\n<li>Registration and licensing of all domestic dogs</li>\n<li>Restraint of dogs in public places</li>\n<li>Immediate destruction of dogs and cats bitten by rabid animals</li>\n<li>Quarantine for about 6 months for imported dogs</li>\n<li>Health education of people regarding the care of dogs and the prevention of rabies.</li>\n</ul>\n</li>\n</ul>",
      "correct_choice_id": 202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Prophylaxis with oral erythromycin</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Prophylaxis with erythromycin and diphtheria antitoxin</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Nothing is required</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Immunize with a booster of diphtheria toxoid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 5-year-old boy presents with a sore throat since two days. Examination revealed grayish white pseudomembrane around his tonsil. If diphtheria is suspected, what prophylactic step should be taken for the 3 years old younger siblings who have received immunisation as per the immunisation schedule?</span></p>",
      "unique_key": "DT1231644",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231644,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Providing prophylaxis with oral erythromycin to the 3-year-old younger siblings is the appropriate course of action.</p>\n<p><strong>Prophylaxis of contacts: </strong></p>\n<ul>\n<li>Contacts should be throat swabbed, and their immunity status should be determined.</li>\n<li>Close contacts such as household members or anyone with direct exposure to the patient should receive prophylaxis to prevent carriage and transmission.</li>\n<li>Preferred agents are <strong>penicillin G</strong>or <strong>erythromycin</strong>.</li>\n<li>Recommended dosage:\n<ul>\n<li><strong>Penicillin G benzathine (single IM dose)</strong>:\n<ul>\n<li>&lt; 6 years: <strong>600,000 units IM</strong></li>\n<li>&ge; 6 years: <strong>2 million units IM</strong></li>\n</ul>\n</li>\n<li><strong>Erythromycin</strong>: <strong>500 mg orally, four times daily for 7-10 days</strong></li>\n</ul>\n</li>\n<li>Where a primary immunisation or booster dose of diphtheria toxoid was received more than 5 years before, only a booster dose of diphtheria toxoid needs to be given. <em>(Option D ruled out)</em></li>\n<li>Non-immunised close contacts should receive prophylactic penicillin or erythromycin. They should be given 1000-2000 units of diphtheria antitoxin and actively immunised against diphtheria. <em>(Option B ruled out)</em></li>\n</ul>",
      "correct_choice_id": 211,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer the full course of the tetanus vaccine</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer a full dose of tetanus toxoid with tetanus immunoglobulin (TIG)</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Give a single booster dose of tetanus toxoid</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">No vaccination required</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A person presents 4 hours after sustaining a clean, minor wound without laceration. His last tetanus toxoid dose was 10 years ago. What is the next appropriate step in management?</span></p>",
      "unique_key": "DT1231645",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231645,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The recommended approach for individuals with clean, minor wounds who have received a tetanus vaccine within the last 10 years is to administer a single dose of tetanus toxoid vaccine (TT). This helps boost immunity against tetanus and protects against potential tetanus infection from the wound.</p>\n<p><strong>Tetanus post-exposure prophylaxis:</strong></p>\n<p>Immunity Category:</p>\n<ul>\n<li>Category A - Completed course of toxoid/booster &lt; 5 years ago</li>\n<li>Category B - Completed course of toxoid/ booster &gt; 5 years ago&amp; &lt;10years ago</li>\n<li>Category C - Completed course of toxoid/booster&gt; 10 yrs. ago</li>\n<li>Category D - Not completed course of Toxoid/ immune status unknown</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250925f9c8ca7d-bec4-4ef4-a770-b9c93de3a2ce.png\">",
      "correct_choice_id": 223,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Prevention of non-communicable diseases</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Universal immunisation</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Promoting family planning</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Ensuring safe water and sanitation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Mission Indradhanush is a Government of India initiative aimed at:</span></p>",
      "unique_key": "DT1231646",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231646,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Mission Indradhanush is a flagship initiative of the Government of India aimed at achieving full immunisation coverage for all children and pregnant women in the country.</p>\n<p><strong>Mission Indradhnaush:</strong></p>\n<ul>\n<li>Launched in December 2014 by the Ministry of Health and Family Welfare, Mission Indradhanush aims to ensure that every child under the age of two years and pregnant women are fully immunised against seven vaccine-preventable diseases.</li>\n<li>The extended phase of Mission Indradhanush - <strong>Intensified Mission Indradhanush 2.0</strong>, aims at 8 vaccine-preventable diseases, which include:\n<ul>\n<li>Tuberculosis</li>\n<li>Measles</li>\n<li>Meningitis and pneumonia - Hemophilus influenzae b</li>\n<li>Diphtheria</li>\n<li>Hepatitis B</li>\n<li>Tetanus</li>\n<li>Whooping cough</li>\n<li>Poliomyelitis</li>\n</ul>\n</li>\n</ul>\n<p><strong>Intensified mission Indradhanush programmes:</strong></p>\n<ul>\n<li>Intensified mission Indradhanush 3.0: \n<ul>\n<li>Main focus was to cover children &amp; pregnant women who missed routine immunisation during the COVID-19 pandemic</li>\n<li>Targeted 12 vaccine-preventable diseases; included JE, RV, PCV, and MR in the initial list.</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li>Intensified mission Indradhanush 4.0: Targeted children born in or after Feb 2020 &amp; due for one or more vaccines.</li>\n</ul>\n<ul>\n<li>Intensified mission Indradhanush 5.0: A vaccine catch-up campaign, which focuses on reaching zero-dose children aged between 0-5 years and pregnant women who might have missed any vaccine doses in the National immunisation schedule.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Prevention of non-communicable diseases (Option A): </strong>Non-communicable diseases are addressed through programs such as the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke.</p>\n<p><strong>Promoting family planning (Option C):</strong> Family planning programs focus on contraceptive services, maternal and child health, and reproductive health. These are covered under the National Family Welfare Programme and specific schemes like Mission Parivar Vikas.</p>\n<p><strong>Ensuring safe water and sanitation (Option D):</strong> Safe water and sanitation are critical for public health and disease prevention, particularly in preventing waterborne and faecal-oral diseases. Safe water and sanitation are addressed through schemes like the Swachh Bharat Mission and Jal Jeevan Mission.</p>",
      "correct_choice_id": 232,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Killed vaccine</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Conjugated</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Toxoid</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Live vaccine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An unvaccinated 6-year-old develops fever, sore throat, and a greyish membrane over the tonsils. The disease could have been prevented by a vaccine included in the National immunisation schedule. The recommended vaccine belongs to which type?</span></p>",
      "unique_key": "DT1231649",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231649,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The clinical presentation suggests diphtheria, which could be prevented by the diphtheria vaccine included in DPT and pentavalent formulations.</li>\n<li>Diphtheria vaccine is a toxoid; it contains diphtheria toxoid, which is an inactivated form of the toxin produced by Corynebacterium diphtheriae, the bacterium that causes diphtheria.</li>\n<li>The toxoid stimulates the immune system to produce antibodies that neutralise the toxin, protecting against diphtheria.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Killed vaccine (Option A): </strong>Killed vaccines, also known as inactivated vaccines, contain pathogens that have been killed or inactivated so that they cannot cause disease. Examples of killed vaccines include the influenza vaccine and IPV (inactivated poliovirus vaccine).</p>\n<p><strong>Conjugated (Option B):</strong> In conjugated vaccines, polysaccharide antigens from bacterial surfaces are chemically linked to a protein that T-cells recognise to boost immunity. These vaccines are typically used to prevent bacterial infections such as pneumococcal disease and meningococcal disease.</p>\n<p><strong>Live vaccine (Option D)</strong>: Live vaccines contain weakened or attenuated forms of pathogens that can still replicate in the body but usually do not cause disease. Examples of live vaccines include the measles, mumps, and rubella (MMR) vaccine and the oral polio vaccine (OPV).</p>",
      "correct_choice_id": 243,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">TT only</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">Td vaccine with tetanus immunoglobulin</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">Td vaccine only</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">Start on antibiotics</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old male presents to the emergency department with a severe crush injury to the hand. His last tetanus toxoid dose was at the age of 25 years. After thorough wound cleaning, what is the next appropriate step in management?</span></p>",
      "unique_key": "DT1231662",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231662,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>For severe crush injuries or contaminated wounds, if it has been over 5 years since the last tetanus toxoid (TT) dose, both a tetanus toxoid-containing vaccine (Td) and tetanus immunoglobulin should be administered.</li>\n<li>Td vaccination provides active immunity against tetanus, while tetanus immunoglobulin provides immediate passive immunity.</li>\n</ul>\n<p><strong>Tetanus Post-exposure prophylaxis:</strong></p>\n<p>Immunity Category:</p>\n<ul>\n<li>Category A - Completed course of toxoid/booster &lt; 5 years ago</li>\n<li>Category B - Completed course of toxoid/ booster &gt; 5 years ago&amp; &lt;10years ago</li>\n<li>Category C - Completed course of toxoid/booster&gt; 10 yrs. ago</li>\n<li>Category D - Not completed course of Toxoid/ immune status unknown</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025092582b6f87c-9b9a-4e50-871c-05ff52d2aea8.png\">",
      "correct_choice_id": 252,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 27,
      "choices": [
        {
          "id": 261,
          "text": "<p><span style=\"font-size:12.0pt;\">i & ii</span></p>"
        },
        {
          "id": 262,
          "text": "<p><span style=\"font-size:12.0pt;\">ii & iii</span></p>"
        },
        {
          "id": 263,
          "text": "<p><span style=\"font-size:12.0pt;\">i & iii</span></p>"
        },
        {
          "id": 264,
          "text": "<p><span style=\"font-size:12.0pt;\">iii & iv</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 2-year-old child with nephrotic syndrome is planned to start on steroids. Before starting treatment, which of the following is/ are true about vaccination?<br>  i) Follow the routine immunisation schedule without changes<br> ii) The pneumococcal vaccine should be administered as per guidelines<br> iii) Only killed vaccines are safe and should be given<br> iv) Live vaccines should be avoided</span></p>",
      "unique_key": "DT1231678",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231678,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Children with nephrotic syndrome on steroids should continue receiving vaccines according to the routine immunisation schedule.</li>\n<li>Vaccination helps protect them from preventable infections, which is especially important since steroid therapy can weaken their immune system.</li>\n<li>The pneumococcal vaccine is recommended for children with nephrotic syndrome, as they are at <strong>increased risk of pneumococcal infections</strong>.</li>\n<li>Therefore, it is important to administer the Pneumococcal vaccine as per the regular vaccination schedule to protect against pneumococcal diseases, including pneumonia, meningitis, and bacteraemia.</li>\n<li>During immunosuppression, live vaccines (such as OPV, BCG, and MMR) are generally avoided due to the risk of causing disease.</li>\n<li>However, routine killed (inactivated) vaccines can and should be given. Some live vaccines may be administered safely before starting steroids or after immunosuppression ends.</li>\n</ul>",
      "correct_choice_id": 261,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 28,
      "choices": [
        {
          "id": 271,
          "text": "<p><span style=\"font-size:12.0pt;\">Diphtheria</span></p>"
        },
        {
          "id": 272,
          "text": "<p><span style=\"font-size:12.0pt;\">Meningococci</span></p>"
        },
        {
          "id": 273,
          "text": "<p><span style=\"font-size:12.0pt;\">Rota virus infection</span></p>"
        },
        {
          "id": 274,
          "text": "<p><span style=\"font-size:12.0pt;\">Zoster</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Besides the influenza vaccine, which of the following vaccine-preventable diseases is commonly recommended for immunisation in the elderly?</span></p>",
      "unique_key": "DT1231685",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231685,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Influenza and herpes zoster (shingles) vaccines are commonly recommended for elderly individuals.</p>\n<ul>\n<li>Immunisation for the elderly is crucial to protect them from vaccine-preventable diseases, as ageing can weaken the immune system and make individuals more susceptible to infections.</li>\n<li>While the<strong>influenza vaccine</strong> is widely recommended, the zoster vaccine is also crucial. Shingles, caused by reactivation of the<strong> varicella-zoster virus</strong>, becomes more common after age 50 as immunity declines.</li>\n<li>Vaccination against shingles helps reduce the risk of the disease and its complications, such as postherpetic neuralgia.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Diphtheria (Option A): </strong>Diphtheria is caused by Corynebacterium diphtheriae and is primarily a childhood infection. Since diphtheria risk decreases with age, it is not a priority for elderly immunisation.</p>\n<p><strong>Meningococci (Option B):</strong> Meningococcal disease, caused by <em>Neisseria meningitidis</em>, can cause serious infections like meningitis. Although older adults have a lower risk than infants and adolescents, those with certain conditions or travellers to high-risk areas may be susceptible. However, meningococcal vaccination is not generally recommended for all elderly individuals.</p>\n<p><strong>Rotavirus infection (Option C): </strong>Rotavirus primarily affects infants and young children, causing gastroenteritis with symptoms such as diarrhoea and vomiting. It is not recommended for the elderly population.</p>",
      "correct_choice_id": 274,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}